Rapibloc 300 mg, Pulver zur Herstellung einer Infusionslösung - Swissmedic Key 68611001 Registration Holder OrPha Swiss GmbH Name Rapibloc 300 mg, Pulver zur Herstellung einer Infusionslösung Date of registration 19.10.2022 Introduction of Sequence 19.10.2022 ATC-Classification Landiolol (C07AB14) Revision date WHO WHO-DDD Valid until 18.10.2027 Index Therapeuticus (BSV) Show package size Index Therapeuticus (Swissmedic) 02.03. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680686110014 Medication Code Synthetika Pharmacode Disponibility
Composition landiololi hydrochloridum 300 mg corresp. landiololum 280 mg, mannitolum, natrii hydroxidum corresp. natrium max. 4.6 mg, pro vitro. Packungsbestandteile Galenic Form Lyophilisate Excipiens Active Agent Dose Landiololi Hydrochloridum 300 mg correspond Landiololum 280 mg
Inactive agents Mannitol Sodium Hydroxide
Source Data was imported : 04.11.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
